MedCap
MCAP.ST
#5925
Rank
C$1.13 B
Marketcap
$76.94
Share price
-1.17%
Change (1 day)
68.96%
Change (1 year)
Categories

P/E ratio for MedCap (MCAP.ST)

P/E ratio as of December 2024 (TTM): 42.9

According to MedCap's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 42.8582. At the end of 2023 the company had a P/E ratio of 29.1.

P/E ratio history for MedCap from 2009 to 2024

PE ratio at the end of each year

Year P/E ratio Change
202329.16.17%
202227.40.07%
202127.4-49.99%
202054.857.59%
201934.8
20172251006.56%
201620.3-57.79%
201548.2115.33%
201422.449.12%
201315.0-15.63%
201217.814.08%
201115.6-42.71%
201027.2
2008-32.3

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.